AKT1 and breast cancer: They explained the mechanism as an FTO inhibitor restrained pyruvate kinase and hexokinase activity and suppressed BC cell glycolysis, partly through lowering the levels of PI3K, p-PI3K, Akt, and p-Akt, which were members of PI3K/AKT signaling pathway and progress tumor growth (49).